Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study.

Thromb J · 2021 · PMC8670061 · PMID 34906162

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

In the RE-DUAL PCI trial, there was a numerical trend for increased thrombotic endpoints when treating with SAPT plus dabigatran 100 mg twice daily.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.